Effect of Storytelling on Questionnaire Completion and Quality of Collected Data in an E-Cohort
PEGASYS
PEGASYS (Projet d'Expérimentation Sur la Gamification et Analyse du StorYtelling Sur SKEZIA): Randomized Controlled Trial Assessing the Effect of Storytelling on Questionnaire Completion and Data Quality Within the E-Cohort SKETHIS
1 other identifier
interventional
500
1 country
1
Brief Summary
This study is a randomized controlled trial, nested in the SKETHIS e-cohort, aiming to evaluate whether adding a modest, narrative-driven, strorytelling introduction to a Patient-Reported Outcome questionnaire increases completion without compromising data quality. This trial is led by SKEZI, a DeepTech start-up which markets a data collection solution and carries out the InnoPRO program, aimed at generating new knowledge in the field of e-cohorts.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2026
CompletedFirst Submitted
Initial submission to the registry
March 11, 2026
CompletedFirst Posted
Study publicly available on registry
March 16, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2026
CompletedMarch 16, 2026
March 1, 2026
3 months
March 11, 2026
March 14, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Completion rate
Proportion of participants who complete the Patient-Reported Outcome questionnaire within 30 days after the questionnaire is first sent, calculated as number of participants who fully completed the questionnaire divided by total number of participants included in the study (or arm)
30 days after sending the questionnaire
Secondary Outcomes (3)
Completion rate for non-mandatory questions
30 days after sending the questionnaire
Ratio number of answered questions over time spent on the questionnaire
30 days after sending the questionnaire
Internal validity of the Patient-Reported Outcome questionnaire
30 days after sending the questionnaire
Other Outcomes (5)
Global Physical Activity Questionnaire (GPAQ) Score
30 days after sending the questionnaire
Participants' satisfaction
30 days after sending the questionnaire
Participants' satisfaction open-ended question
30 days after sending the questionnaire
- +2 more other outcomes
Study Arms (2)
Storytelling
EXPERIMENTALSelf-administrated Patient-Reported Outcome questionnaire (Global Physical Activity Questionnaire) enhanced by storytelling with a short narrative introduction and minimal visual design (color palette, icons, illustrations).
Neutral
NO INTERVENTIONSelf-administrated Patient-Reported Outcome questionnaire (Global Physical Activity Questionnaire) presented as is (no narrative, no visual embellishment).
Interventions
In the context of the SKETHIS e-cohort, participants receive an email inviting them to complete a new online questionnaire regarding their physical activity. Participants are unaware that the experiment is being conducted or that the questionnaire uses storytelling.
Eligibility Criteria
You may qualify if:
- Being a current SKETHIS participant (eligibiliy criteria: being 18 or older, living in France, reading and understanding French, having a digital device with internet access and a valid e-mail address)
- Having completed the main SKETHIS questionnaire and the socio-demographic information questionnaire
- Providing consent to participate to the study
You may not qualify if:
- \- Answering "I am unable to walk out" to the EQ-5D mobility item part of the main SKETHIS questionnaire (cannot complete Global Physical Activity Questionnaire)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- SKEZIlead
Study Sites (1)
SKEZI
Paris, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Participants are unaware that the trial was being conducted, and the researchers and data analysts were blind to participants' assigned groups.
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- CEO, PhD, MD
Study Record Dates
First Submitted
March 11, 2026
First Posted
March 16, 2026
Study Start
March 1, 2026
Primary Completion
June 1, 2026
Study Completion
June 1, 2026
Last Updated
March 16, 2026
Record last verified: 2026-03